Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N-vanillylnonanamide
2. Vanillyl-n-nonylamide
3. Vanillylnonanamide
1. 2444-46-4
2. N-vanillylnonanamide
3. Pseudocapsaicin
4. Pelargonic Acid Vanillylamide
5. N-vanillylnonamide
6. N-vanillylpelargonamide
7. N-(4-hydroxy-3-methoxybenzyl)nonanamide
8. Nonanoic Acid Vanillylamide
9. N-nonanoyl Vanillylamide
10. Vanillyl-n-nonylamide
11. Vanillyl Pelargonic Amide
12. Pelargonyl Vanillylamide
13. Hydroxymethoxybenzyl Pelargonamide
14. Nonylic Acid Vanillylamide
15. Vanillyl N-nonoylamide
16. Nonanamide, N-vanillyl-
17. Nonivamide [inn]
18. Nonanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-
19. Nonanoyl Vanillylamide
20. Desmethyldihydrocapsaicin
21. N-[(4-hydroxy-3-methoxyphenyl)methyl]nonanamide
22. Fema No. 2787
23. N-vanillylnonanoamide
24. Hansaplast
25. Nsc 172795
26. Nonanoyl 4-hydroxy-3-methoxybenzylamide
27. N-vanillyl Nonanamide
28. Nonylic Acid Vanillyamide
29. N-((4-hydroxy-3-methoxyphenyl)methyl)nonanamide
30. N-((hydroxy-3-methoxyphenyl)methyl)4-nonanamide
31. Nsc-172795
32. Chembl75124
33. Chebi:46936
34. S846b891or
35. Nonivamide (inn)
36. Ah-23491x
37. Mfcd00017286
38. Nonanamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-
39. Ncgc00016089-05
40. Nonylvanylamide
41. Dsstox_cid_14769
42. Dsstox_rid_79200
43. Dsstox_gsid_34769
44. Nonivamida
45. Nonivamidum
46. Nonivamidum [inn-latin]
47. Nonivamida [inn-spanish]
48. Cas-2444-46-4
49. Pava
50. 8-nordihydrocapsaicin
51. N-vanillyl-nonanamide
52. Nonanoylvanillyl Amide
53. Vanillyl N-nonylamide
54. Capsaicin (synthetic)
55. N-((4-hydroxy-3-methoxyphenyl)methyl)-nonanamide
56. N-[(4-hydroxy-3-methoxyphenyl)methyl]-nonanamide
57. Einecs 219-484-1
58. Brn 2144300
59. Capscaisin
60. Unii-s846b891or
61. N-nonylvanylamide
62. Pava Spray
63. Hansaplast (tn)
64. Nonanoylvanilylamide
65. Nonylic Vanillamide
66. Synthetic Capsaicin
67. Nonoyl Vanillylamide
68. Psva
69. Nonylicacidvanillylamide
70. Spectrum_000311
71. Pelargonoyl Vanillylamide
72. Specplus_000799
73. N-pelargonylvanillylamide
74. Spectrum2_001091
75. Spectrum4_000916
76. Spectrum5_001853
77. Lopac-v-9130
78. N-vanillylnonanamide, 8ci
79. Nonivamide [mart.]
80. Nonivamide [who-dd]
81. Lopac0_001218
82. Schembl81939
83. Kbiogr_001412
84. Kbioss_000791
85. Mls002153373
86. Divk1c_006895
87. Spectrum2300192
88. Spbio_001162
89. N-pelargonic Acid Vanillylamide
90. Dtxsid1034769
91. Fema 2787
92. Kbio1_001839
93. Kbio2_000791
94. Kbio2_003359
95. Kbio2_005927
96. Hh 50
97. Hms2234e23
98. Hms3374k02
99. Hms3885c14
100. Pharmakon1600-01506172
101. Albb-025790
102. Zinc1697652
103. Tox21_110302
104. Tox21_301218
105. Bdbm50044767
106. Ccg-39764
107. Nsc172795
108. Nsc760391
109. S3935
110. Akos001719931
111. N-vanillylnonanamide, >=97%, Powder
112. Tox21_110302_1
113. Ac-4807
114. Db11324
115. Nsc-760391
116. 8-methyl-n-vanillyl-trans-b-nonenamide
117. N-vanillylnonanamide, Analytical Standard
118. Ncgc00016089-01
119. Ncgc00016089-02
120. Ncgc00016089-03
121. Ncgc00016089-04
122. Ncgc00016089-06
123. Ncgc00094463-01
124. Ncgc00094463-02
125. Ncgc00094463-03
126. Ncgc00094463-04
127. Ncgc00255553-01
128. As-13519
129. Hy-17568
130. Smr001230764
131. N-(4-hydroxy-3-methoxybenzyl)nonanamide #
132. Eu-0101218
133. Ft-0603609
134. Ft-0623446
135. M0900
136. Nonanamide, N-(4-hydroxy-3-methoxybenzyl)-
137. 4-hydroxy-3-methoxy-n-(1-oxononyl)-benzamide
138. D08282
139. V 9130
140. V-3000
141. Ab00053157_06
142. Hydroxymethoxybenzyl Pelargonamide [inci]
143. N-((4-hydroxy-3-methoxyphenyl)methyl)-nonanamid
144. Nonanamide, N-((4-hydroxy-3-methoxyphenyl)meth
145. 444n464
146. A817309
147. Nonivamide (constituent Of Capsicum) [dsc]
148. Q420228
149. Sr-01000076196
150. Sr-01000076196-1
151. N-[(4-hydroxy-3-methoxyphenyl)methyl]nonanamide, 9ci
152. Z373586944
153. N-nonanoyl-4-hydroxy-3-methoxybenzyl-amide [fhfi]
154. Nonivamide, European Pharmacopoeia (ep) Reference Standard
155. N-(4-hydroxy-3-methoxybenzyl)nonanamide, N-vanillylpelargonamide, Nonanoic Acid Vanillylamide, Nonylvanylamide, Pelargonic Acid Vanillylamide
Molecular Weight | 293.4 g/mol |
---|---|
Molecular Formula | C17H27NO3 |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 10 |
Exact Mass | 293.19909372 g/mol |
Monoisotopic Mass | 293.19909372 g/mol |
Topological Polar Surface Area | 58.6 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 283 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Nonivamide is used as a topical analgesic and is also used as a flavoring ingredient,,.
Relieves minor aches and pains of muscles and joints,.
Limited information is available on pharmacokinetics and metabolism of nonivamide. For the closely related [DB06774] and other capsaicinoids, gastrointestinal absorption is rapid and almost entirely complete in studies of rats (oral dose of about 10 to 15 mg/kg of combined capsaicin and dihydrocapsaicin) with about 85% of the dose being absorbed within 3 hours. Both substances undergo first-pass metabolism in the liver and partly metabolized at the site of absorption.
About 7 minutes.
Nonivamide is a naturally occurring analog of [DB06774], isolated from peppers, described to produce effects similar to [DB06774]. It is an agonist of the VR1 (vanilloid/TRPV1 receptor). It serves as a transient agonist of these receptors, which are potentiated by pro-inflammatory drugs, a phenomenon that leads to thermal hyperalgesia, or increased heat sensation. Nonivamide has been shown to stimulate afferent neurons with about half the potency of [DB06774]. Agonism of the VR1 (TRPV1) (vanilloid) receptor by Nonivamide was demonstrated to induce the release of Ca2+ from the endoplasmic reticulum (ER) of human lung cells, producing ER stress and cell death [MSDS]. Nonivamide, like other capsaicinoids, acts on the vanilloid receptors located in the peripheral afferent nerve fibers, providing short-acting irritant and algesic properties. Applied dermally, these substances act by stimulating sensitive chemoreceptors of the skin and by reflex, hyperemia and a local elevation in temperature. After repetitive administration, capsaicinoids have been reported to lead to desensitization to nociceptive stimuli possibly by long-acting depletion of peptide neurotransmitters (substance P) from peripheral sensory neurons. Capsaicinoids can modulate muscle tone (in bladder, bronchus etc.). Intravenous injection of nonivamide to rats (10 g/kg) has been found to lead to bradycardia. The cardiovascular effects are partly explained by substance P release. Nonivamide given to rats subcutaneously (1 mg/kg) was found to cause body temperature decrease, vasodilatation, and increased salivation. Capsaicinoids have shown to illicit bronchospastic effects in guinea pigs. Capsaicin and its analogs were reported to increase barbiturate sleeping time in rats by interacting with hepatic metabolizing enzymes.
Registration Number : 222MF10228
Registrant's Address : 36 Hoping Street, Louchu, Taoyuan 33842, Taiwan
Initial Date of Registration : 2010-09-10
Latest Date of Registration : 2010-09-10
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
About the Company : Founded in 1987, Transo-Pharm is a fully licensed and certified global distributor of pharmaceutical components for the health and veterinary industries. The company supports its c...
About the Company : Formosa Laboratories Inc. founded in Taiwan since 1995 started with API business and has been serving customers worldwide. As an established API manufacturer receiving GMP inspecti...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Nonivamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nonivamide, including repackagers and relabelers. The FDA regulates Nonivamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nonivamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nonivamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nonivamide supplier is an individual or a company that provides Nonivamide active pharmaceutical ingredient (API) or Nonivamide finished formulations upon request. The Nonivamide suppliers may include Nonivamide API manufacturers, exporters, distributors and traders.
click here to find a list of Nonivamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Nonivamide Drug Master File in Japan (Nonivamide JDMF) empowers Nonivamide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Nonivamide JDMF during the approval evaluation for pharmaceutical products. At the time of Nonivamide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Nonivamide suppliers with JDMF on PharmaCompass.
Nonivamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nonivamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nonivamide GMP manufacturer or Nonivamide GMP API supplier for your needs.
A Nonivamide CoA (Certificate of Analysis) is a formal document that attests to Nonivamide's compliance with Nonivamide specifications and serves as a tool for batch-level quality control.
Nonivamide CoA mostly includes findings from lab analyses of a specific batch. For each Nonivamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nonivamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Nonivamide EP), Nonivamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nonivamide USP).
LOOKING FOR A SUPPLIER?